Official Journal Publication

Journal of PhytoPharmaceutical and Advanced Chemistry

Short Name: JPPAC• ISSN: 3139-9266• Peer-Reviewed Open Access

2026Volume 1 Issue 03, Pages 212-218• Published: October 17, 2026

Comparative In Vitro Evaluation of Berberine–Chlorogenic Acid and Its Phytosome-Based Hydrogel Against Candida albicans

Contributing Authors
Namita Gajanan NarvekarSimachal PandaVijay Arjun Jagtap
Digital Object Identifier (DOI):https://doi.org/10.66220/1vdqms31

Abstract

Candida albicans is an important fungal pathogen associated with superficial and opportunistic infections, highlighting the need for effective topical antifungal formulations. The present study aimed to evaluate the in vitro antifungal activity of an optimized berberine–chlorogenic acid (B+CA) phytosome-based hydrogel against C. albicans and compare its performance with the pure B+CA combination and ketoconazole. The optimized F1 formulation contained berberine and chlorogenic acid in a 1:1 ratio and was evaluated using the agar well diffusion method. Ketoconazole served as the standard antifungal drug, while normal control and blank hydrogel were included as controls. Antifungal activity was assessed by measuring the zone of inhibition (ZOI) following incubation. The results demonstrated that the B+CA phytosome-based hydrogel produced a ZOI of 22.90 mm, whereas the pure B+CA combination exhibited a ZOI of 18.50 mm. The optimized F1 formulation showed an approximately 23.8% greater inhibition-zone diameter than the pure combination, indicating improved antifungal performance following phytosome-based incorporation into the hydrogel matrix. Ketoconazole demonstrated the highest antifungal activity, with a ZOI of 31.44 mm. Neither the normal control nor the blank hydrogel produced a measurable inhibition zone. The enhanced activity of F1 may be associated with improved dispersion and presentation of the active constituents and the contribution of the hydrogel matrix to formulation retention and diffusion. In conclusion, the findings support the potential of the B+CA phytosome-based hydrogel as a promising topical antifungal formulation. Further safety, skin compatibility, and in vivo studies are required to establish its therapeutic suitability.

Export Citation

Generate ready-to-use citations in standard scientific formats

Narvekar, N. G., Panda, S., & Jagtap, V. A. (2026). Comparative In Vitro Evaluation of Berberine–Chlorogenic Acid and Its Phytosome-Based Hydrogel Against Candida albicans. Journal of PhytoPharmaceutical and Advanced Chemistry, Vol. 1(No. 03), pp. 212-218. https://doi.org/10.66220/1vdqms31

Cited References

18 References
  1. 01.

    Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence, 13, 89–121 (2022). doi: 10.1080/21505594.2021.2019950.

  2. 02.

    2. Cornely OA, Sprute R, Bassetti M, Chen SCA, Groll AH, Kurzai O, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280–93. doi: 10.1016/S1473-3099(24)00749-7.

  3. 03.

    3. Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect. Drug Resist., 10, 249–59 (2017). doi: 10.2147/IDR.S124918.

  4. 04.

    4. Mehra M, Sheorain J, Bakshi J, Thakur R, Grewal S, Dhingra D, Kumari S. Synthesis and evaluation of berberine loaded chitosan nanocarrier for enhanced in-vitro antioxidant and anti-inflammatory potential. Carbohydr. Polym. Technol. Appl., 7, (2024). doi: 10.1016/j.carpta.2024.100474.

  5. 05.

    5. Saparbekova AA, Kantureyeva GO, Kudasova DE, Konarbayeva ZK, Latif AS. Potential of phenolic compounds from pomegranate (Punica granatum L.) by-product with significant antioxidant and therapeutic effects: A narrative review. Saudi J. Biol. Sci., 30, (2023). doi: 10.1016/j.sjbs.2022.103553.

  6. 06.

    6. Brescini L, Fioriti S, Morroni G, Barchiesi F. Antifungal combinations in dermatophytes. J. Fungi, 7, (2021). doi: 10.3390/jof7090727.

  7. 07.

    7. Noor-ul-Ain R, Ilyas N, Saeed M, Subramaniam G, Mastinu A. Advances in pharmaceutical and biomedical applications of plant–based nano-biopolymers with special emphasis on vaginal drug delivery systems: A review. Ind. Crops Prod., 225, (2025). doi: 10.1016/j.indcrop.2025.120592.

  8. 08.

    8. Lal DK, Kumar B, Saeedan AS, Ansari MN. An Overview of Nanoemulgels for Bioavailability Enhancement in Inflammatory Conditions via Topical Delivery. Pharmaceutics, 15, (2023). doi: 10.3390/pharmaceutics15041187.

  9. 09.

    9. Hajare PK, Reddy MR, Somvanshi YD, Dhumekar VA. Formulation and evaluation of Niosomal cream from moringa leaf extract for enhanced Antifungal Activity. J. Drug Deliv. Ther., 15, 113–8 (2025). doi: 10.22270/jddt.v15i4.7097.

  10. 10.

    10. Thang NH, Chien TB, Cuong DX. Polymer-Based Hydrogels Applied in Drug Delivery: An Overview. Gels, 9, (2023). doi: 10.3390/gels9070523.

  11. 11.

    11. Tsang MSM, Jiao D, Chan BCL, Hon KL, Leung PC, Lau CBS, Wong ECW, Cheng L, Chan CKM, Lam CWK, Wong CK. Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation. Molecules, 21, (2016). doi: 10.3390/molecules21040519.

  12. 12.

    12. Nobile CJ, Johnson AD. Candida albicans Biofilms and Human Disease. Annu. Rev. Microbiol., 69, 71–92 (2015). doi: 10.1146/annurev-micro-091014-104330.

  13. 13.

    13. Mace MAM, Reginatto CL, Silva VRJ, Pinheiro ACS, Silva LS da, Moura DJ, Fuentefria AM, Soares RMD. 3D Printable Alginate–Chitosan Hydrogel Loaded With Ketoconazole Exhibits Anticryptococcal Activity. Biopolymers, 116, (2025). doi: 10.1002/bip.23638.

  14. 14.

    14. Alishlah T, Nuri N, Dianasari D, Rahman Hakim A. Chlorogenic Acid Quantification and Antioxidant Activity of NADES Extracts from Robusta Green Coffee Beans (Coffea canephora) Using MAE and UAE Methods for Cosmetic Raw Material. J. Pharm. Sci., 1866–76 (2025). doi: 10.36490/journal-jps.com.v8i3.937.

  15. 15.

    15. Jin D, Amna D, Wang Q, Yao J, Zhang X, Li Z, Lang H, Chen Y, Zhong K, Li S, Shen Q. Preparation of citric acid crosslinked starch-chitosan hydrogels and their application in resveratrol delivery. Int. J. Food Sci. Technol., 61, (2026). doi: 10.1093/ijfood/vvag023.

  16. 16.

    16. Gong Y, Li T, Yu C, Sun S. Candida albicans heat shock proteins and Hsps-associated signaling pathways as potential antifungal targets. Front. Cell. Infect. Microbiol., 7, (2017). doi: 10.3389/fcimb.2017.00520.

  17. 17.

    17. Thongsuksaengcharoen S, Samosorn S, Songsrirote K. A Facile Synthesis of Self-Catalytic Hydrogel Films and Their Application as a Wound Dressing Material Coupled with Natural Active Compounds. ACS Omega, 5, 25973–83 (2020). doi: 10.1021/acsomega.0c03414.

  18. 18.

    18. Dutta SK, Singh CV, Hans MK, Bathla S, Singh V, Mishra S. Antibacterial Efficacy of Mineral Trioxide Aggregate, Bioactive Glass and Epoxy‑Resin Based Sealer: An In‑Vitro Interventional Study. J. Pharm. Bioallied Sci., 16, S619–22 (2024). doi: 10.4103/jpbs.jpbs_901_23.

Suggested & Related Publications

Articles in related pharmaceutical, biomedical, and life sciences research on PharmSciGate

Explore Directory →
JPTN2026 • pp. 119-125

In Vitro Antifungal Evaluation of a Posaconazole-Loaded Menthosomal Hydrogel Against Candida albicans

Bhosale, Namita Subhanrao; Upadhyay, Dinesh Kumar; Jagtap, Vijay Arjun

Posaconazole is a broad-spectrum triazole antifungal agent used against a range of pathogenic fungi. The present study aimed to evaluate the in vitro antifungal activity of an optimized Posaconazole-loaded Menthosomes hydrogel (PMLH) against Candida albicans. The antifungal activity was assessed using the agar well diffusion method, with the zone of inhibition (ZOI) used as the primary response. The optimized PMLH formulation was evaluated in comparison with a marketed Posaconazole formulation and Posaconazole active pharmaceutical ingredient (API). A drug-free hydrogel base and blank well were included as controls to determine the contribution of the formulation matrix and experimental setup to the observed antifungal activity. The optimized PMLH contained 90.20 ± 0.6% drug content and was tested at an equivalent Posaconazole concentration of 10 µg/mL. Following incubation, the ZOI was measured in millimetres. The PMLH exhibited a ZOI of 26.9 ± 1.7 mm, compared with 24.4 ± 1.5 mm for the marketed Posaconazole formulation and 18.8 ± 1.3 mm for Posaconazole API. No visible inhibition was observed for either the drug-free hydrogel base or blank. The larger inhibition zone produced by PMLH indicates enhanced apparent antifungal activity under the conditions of the agar diffusion assay and may be associated with improved drug dispersion and diffusion from the Menthosomal hydrogel matrix. However, the observed ZOI is also influenced by formulation viscosity, drug release, partitioning, and diffusion. Overall, the findings support the potential of PMLH as a promising formulation approach for improving the apparent antifungal performance of Posaconazole against C. albicans. Further standardized studies are warranted to confirm these findings.

JPTN2026 • pp. 152-158

In Vitro Antifungal Evaluation of a Berberine–Ellagic Acid Phytosome-Based Hydrogel Against Candida albicans

Narvekar, Namita Gajanan; Panda, Simachal; Jagtap, Vijay Arjun

Candida albicans is an important fungal pathogen associated with superficial and opportunistic infections, creating a need for effective topical antifungal delivery systems. The present study aimed to evaluate the in vitro antifungal activity of an optimized berberine–ellagic acid (B+E) phytosome-based hydrogel against C. albicans. The optimized B+E phytosomes were incorporated into a Carbopol 940 and HPMC K15-based hydrogel matrix to develop a topical formulation. The antifungal activity was evaluated using the agar well diffusion method against C. albicans. The study included the pure B+E combination, optimized B+E phytosome hydrogel, ketoconazole as the standard antifungal drug, blank hydrogel, and normal control. Antifungal activity was assessed by measuring the zone of inhibition (ZOI). The optimized B+E phytosome hydrogel exhibited a ZOI of 23.54 mm, compared with 15.29 mm for the pure B+E combination and 26.64 mm for the standard antifungal drug. Thus, the phytosome-based hydrogel demonstrated an approximately 53.89% improvement in inhibition-zone diameter compared with pure B+E and achieved approximately 88.36% of the inhibition produced by the standard treatment. The optimized formulation also showed high drug content, with 95.86 ± 0.52% for berberine and 94.97 ± 0.61% for ellagic acid. The blank hydrogel and normal control showed no detectable inhibition. The enhanced activity may be attributed to improved dispersion and distribution of B+E within the phytosomal system and favorable diffusion characteristics of the hydrogel matrix. Overall, the findings demonstrate the potential of B+E phytosome-based hydrogel as a promising topical antifungal delivery system against C. albicans. Further in vivo and mechanistic studies are warranted.

Full-Text Access

Access Type: Open Access
License:CC BY-NC 4.0
Language:en
Publishing Journal

Journal of PhytoPharmaceutical and Advanced Chemistry

An international, peer-reviewed journal integrating phytopharmaceutical sciences, natural products, and advanced pharmaceutical chemistry.

ISSN:3139-9266
DOI Prefix:10.5530/jppac
Visit Journal Portal
Indexed on PharmSciGate by SPBSRF

This peer-reviewed publication is indexed directly from the publisher repository adhering to Open Archives Initiative (OAI-PMH) metadata standards, Crossref DOI schema, and Google Scholar Highwire Press protocols.